Abstract
Vitamin K is a cofactor for human glutamic acid carboxylase enzymes in multiple tissues and organs. The dominant vitamin K activity is gamma-carboxylation of selective glutamic acid residues on coagulation factors X, IX, VII, and II. Humans predominantly rely on green vegetable dietary sources of vitamin K rather than synthesis of vitamin K by intestinal bacteria. Vitamin K deficiency bleeding in newborns is uncommon, potentially devastating, and preventable with vitamin K prophylaxis. Other causes of vitamin K deficiency include prolonged anorexia, malabsorption, and rapid depletion without adequate intake during acute medical and surgical events. The significance and mechanisms of antibiotic-associated vitamin K deficiency remain controversial and incompletely investigated. Management options for vitamin K deficiency include oral and parenteral vitamin K and coagulation factor replacement. Ingestion of "superwarfarin" rodenticides produces a severe and prolonged coagulopathy with potential for major bleeding complications.
Original language | English |
---|---|
Title of host publication | Management of Bleeding Patients |
Publisher | Springer International Publishing |
Pages | 187-192 |
Number of pages | 6 |
ISBN (Electronic) | 9783030563387 |
ISBN (Print) | 9783030563370 |
DOIs | |
State | Published - Jan 5 2021 |
Keywords
- Vitamin K deficiency bleeding superwarfarin